In the framework of a joint development, Diasorin will use Tecan’s Fluent Laboratory Automation Solution as its nucleic acid extraction platform.
Männerdorf/Switzerland — The new platform will be used in combination with the Diasorin Liaison MDX PCR system to provide the customer with a complete sample to result system for molecular diagnostics.
According to the companies, the Fluent platform will be optimized for use with the Diasorin extraction chemistry and the automated PCR setup of the Liaison MDX 96-well disc. The new development delivers more capacity, high precision and increased speed, the companies claim.
Dr David Martyr, CEO of Tecan, commented: “We are delighted that Diasorin has chosen the Fluent Laboratory Automation Solution as the basis for this new platform. The precision, speed and low volume liquid handling accuracy offered by the Fluent are ideal for molecular diagnostics applications.”